2010 | Deborah Donnell, PhD, Jared M. Baeten, MD, James Kiarie, MBBCh, Katherine K. Thomas, MS, Wendy Stevens, MBBCh, Craig R. Cohen, MD, James McIntyre, MBBCh, Jairam R. Lingappa, MD, and Connie Celum, MD
A prospective cohort study of 3381 African heterosexual HIV-1 serodiscordant couples found that initiating antiretroviral therapy (ART) significantly reduced the risk of HIV-1 transmission. Among HIV-1 infected partners who initiated ART, the risk of transmission was reduced by 92% compared to those who did not. This reduction was primarily due to a significant decrease in plasma HIV-1 RNA levels, which dropped from a median of 4.88 to less than 2.38 log10 copies/mL after ART initiation. Additionally, there was a decrease in unprotected sex, from 6.2% to 3.7% of visits. The highest transmission risk was observed in couples where the HIV-1 infected partner had CD4 counts below 200 cells/mm³ or plasma HIV-1 RNA concentrations above 50,000 copies/mL. In these cases, ART provided the greatest relative prevention benefit. The study also found that ART initiation was associated with increased self-reported condom use. The findings support the use of ART as a prevention strategy, particularly for individuals with high viral loads and low CD4 counts. The study highlights the importance of ART in reducing HIV-1 transmission and emphasizes the need for targeted ART provision to those at highest risk. The results are consistent with previous meta-analyses and suggest that ART can significantly reduce HIV-1 transmission risk. The study also underscores the importance of ongoing research to understand the long-term benefits and risks of ART in HIV-1 prevention.A prospective cohort study of 3381 African heterosexual HIV-1 serodiscordant couples found that initiating antiretroviral therapy (ART) significantly reduced the risk of HIV-1 transmission. Among HIV-1 infected partners who initiated ART, the risk of transmission was reduced by 92% compared to those who did not. This reduction was primarily due to a significant decrease in plasma HIV-1 RNA levels, which dropped from a median of 4.88 to less than 2.38 log10 copies/mL after ART initiation. Additionally, there was a decrease in unprotected sex, from 6.2% to 3.7% of visits. The highest transmission risk was observed in couples where the HIV-1 infected partner had CD4 counts below 200 cells/mm³ or plasma HIV-1 RNA concentrations above 50,000 copies/mL. In these cases, ART provided the greatest relative prevention benefit. The study also found that ART initiation was associated with increased self-reported condom use. The findings support the use of ART as a prevention strategy, particularly for individuals with high viral loads and low CD4 counts. The study highlights the importance of ART in reducing HIV-1 transmission and emphasizes the need for targeted ART provision to those at highest risk. The results are consistent with previous meta-analyses and suggest that ART can significantly reduce HIV-1 transmission risk. The study also underscores the importance of ongoing research to understand the long-term benefits and risks of ART in HIV-1 prevention.